Trial Profile
Single-dose and Steady-state Pharmacokinetics of BIA 9-1067 and Its Metabolites in Healthy Male Elderly Subjects Compared With Those in Healthy Male Young Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Jan 2015
Price :
$35
*
At a glance
- Drugs Opicapone (Primary)
- Indications Parkinson's disease
- Focus Pharmacokinetics
- Sponsors Bial
- 25 Mar 2014 New trial record